Sham showed a decline in MoCA. These findings suggest that intranasal PBM may be a promising adjunctive therapy for PD; further studies are needed to elucidate mechanisms and optimize treatment protocols.
These results suggest that transcranial PBM can increase fMRI BOLD responses locally in some task-related regions in aged subjects. Further research is needed to distinguish neural from vascular effects in transcranial PBM.
Localized PBM modulated these peripheral and central transcriptional responses by reducing IL-6, IP, and kinin receptor expression at specific time points while maintaining elevated IL-10 expression.
Study · November 10, 2026 · Alberto-Silva C et al.
Such trials must prespecify decoder calibration, uncertainty, abstention, safety limits, and mechanistic and clinical endpoints. Closed-loop cognitive modulation therefore defines a translational research agenda for AD.
Notably, tPBM reversed these changes, restored mitochondrial bioenergetics, diminished oxidative stress, and suppressed neuroinflammation, leading to considerable behavioral improvement.
These findings identify alterations in MT-CO2 and SDHB in AD temporal cortex and demonstrate that MT-CO2 contributes to Complex IV-dependent respiration and photobiomodulation-associated bioenergetic enhancement.
Nevertheless, definitive clinical efficacy cannot be confirmed given small sample sizes, heterogeneous intervention protocols, and inconsistent outcomes from controlled trials.
A decrease in CBF from session one to session six was also observed in the right anterior cingulate gyrus (BA32). These findings suggest a biphasic response to TILS and support further investigation of TILS as a potential intervention for cognitive impairment in BD.
Study · October 23, 2026 · Nawrocik-Madrid A et al.
When combined with the 20 participants from the prior pilot study, significant improvement in fatigue by 2.8 ± 0.85 points (p = 0.0033) was observed and sleep duration was also significantly increased by 24.7 ± 10.4 min (p = 0.012).
Stress-induced anxiety-like behaviors were significantly reduced by MLT, with effects similar to those of the combined treatment, which outperformed tPBM alone.
Furthermore, we evaluate how the integration of optogenetic tools and nanomaterials has refined NIR therapies, establishing a foundation for high-precision neurology.
Brain disorders, including neurodegenerative, neuropsychiatric, and cerebrovascular diseases, represent a growing global health challenge contributing to disability and mortality worldwide.
Both the presence of the snake and exposure to its odor elicited anxiety-like risk-assessment behavior in the rodents. In turn, photobiomodulation treatment significantly reduced both the frequency and duration of this behavior, suggesting a potential anxiolytic-like effect.
Distinct wavelength-dependent responses further contribute to therapeutic parameter optimization and support future translational and clinical research.
ConclusionThese findings suggest that short-term tPBM targeting the SMA can enhance motor performance, particularly of the non-dominant hand, and increase sensorimotor alpha and beta power in healthy young adults.
We distinguish focal-local, diffuse/systemic, and local-stimulation/network-mediated accounts of action and identify prospective tests that can discriminate among them.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, marked by the accumulation of amyloid-beta plaques, tau pathology, and synaptic dysfunction, ultimately leading to memory loss, cognitive decline, neuropsychiatric symptoms and neuronal degeneration that impairs daily functioning.